This trial is active, not recruiting.

Condition stroke
Treatment stroke education workshops
Sponsor Hopital Foch
Start date June 2013
End date August 2016
Trial size 199 participants
Trial identifier NCT02834273, 2013/18


The rapid diagnosis and treatment of acute ischemic stroke are critical in the reduction of morbidity, disability and stroke associated mortality Under-education about stroke may prevent people from recognizing symptoms early enough to seek immediate care.

The studies reported on stroke patients managed in stroke center have shown that 39-42% of patients could not name any symptoms of stroke and 36% to 43% no risk factor of stroke.

The stroke patients are therefore a population at high risk for neurological events and cardiac vascular recurrence. However, no studies have evaluated the interest of the development of therapeutic workshops in stroke unit to educate patients about symptoms suggestive of stroke, risk factors and what to do in cases of stroke.

Investigators assume that the setting up of a therapeutic education workshop in the stroke unit may allow a better understanding of the symptoms, risk factors and what to do following stroke. So there is a direct benefit to the patient represented by a better knowledge of stroke (warning signs, risk factors, what to do), improved treatment compliance and reduced risk of recurrence.

More generally, there is a real benefit to promote these messages to the public through the patient and his relatives

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking open label
Primary purpose prevention
Therapeutic Workshop (patients following therapeutic education workshops during their hospitalization)
stroke education workshops
(No Intervention)

Primary Outcomes

Percentage of patients able to recognize at least one sign of stroke, 1 risk factor and what to do in cases of stroke
time frame: 12 months

Secondary Outcomes

Blood pressure
time frame: 12 months
time frame: 12 months
Body Mass Index
time frame: 12 months
Smoking intoxication
time frame: 12 months
Recurrent stroke
time frame: 12 months
Compliance to treatments
time frame: 12 months

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Patients older than 18 years. - Diagnosis of ischemic stroke; - Patients with back home or shorter rehabilitation; - Patients affiliated to a social security scheme; - Patients who consented to participate in writing. Exclusion Criteria: - Patients with cognitive disorders, vigilance, aphasia. - Patients institutionalized.

Additional Information

Official title Impact of Patient Education Following a Stroke on Knowledge of Risk Factors, Stroke Warning Signs and What to do in Cases of Stroke
Principal investigator Bertrand Lapergue, MD PhD
Trial information was received from ClinicalTrials.gov and was last updated in January 2017.
Information provided to ClinicalTrials.gov by Hopital Foch.